Litcius/Paper detail

Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Bradford A. Perez, Sungjune Kim, Min-Hsuan Wang, Ahmad M. Karimi, Chase Powell, Jiannong Li, Thomas J. Dilling, Alberto Chiappori, Kujtim Latifi, Trevor Rose, Austin Lannon, G. Macmillan, James J. Saller, G. Daniel Grass, Stephen A. Rosenberg, Jhanelle E. Gray, Eric B. Haura, Ben Creelan, Tawee Tanvetyanon, Andreas Saltos, Michael Shafique, Theresa A. Boyle, Michael J. Schell, José R. Conejo-García, Scott Antonia

2020International Journal of Radiation Oncology*Biology*Physics46 citationsDOIOpen Access PDF

Topics & Concepts

NivolumabIpilimumabMedicineOncologyRadiation therapyLung cancerChemotherapyStage (stratigraphy)Internal medicinePhases of clinical researchCancerImmunotherapyBiologyPaleontologyLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer | Litcius